Biomedical Strategy Consultants works with small, mid-size and large medtech, biotech and pharmaceutical companies, as well as with life sciences investment groups. Although some of our clients cannot be identified for reasons of confidentiality, we are happy to provide specific references upon request. Here are some examples of our past and on-going engagements:

Pan-Asian business development

Client: Developer of an innovative software-based intensive care ventilator, headquartered in the U.S.

Project outline: Establishment of a pan-Asian distribution network by identifying and carefully evaluating potential distribution partners. Short listed and had face-to-face meetings with 24 potential distributors in 7 countries within 2 months of starting the project. Concluded agreements with distribution partners in all major markets, including one of the leading suppliers of respiratory equipment in Japan. The client subsequently achieved record sales and sales growth in the region.

Market due diligence and interim management

Client: Israeli-Australian developer and manufacturer of a state-of-the-art 3D image-guided surgical navigation systems for dental applications.

Project outline: Conducted market due diligence in preparation for a listing on the Australian stock exchange (ASX). Established an Asia-Pacific regional sales head quarters and provided interim-management services. Recruited key staff. Developed market entry strategies for major Asian markets. Selected and appointed distributors. Provided on-going advice through active participation at Board level of the company’s Asian subsidiary.

Market entry strategy - China

Client: U.S. based developer of a potential breakthrough technology in digital electroacoustic cardiography.

Project outline: Conducted in-depth interviews and detailed market research in three locations in China. All interviews were conducted in Mandarin. Assessed the acceptance of a proposed product value proposition. Developed a market entry strategy. Completed research planning, actual interviews, analysis and final report writing within 3 weeks. A comprehensive final report allowed our client to make informed and intelligent decisions to move forward.

Interim management of Pacific Rim operations

	Client: One of the largest U.S. healthcare groups and a leading provider of a broad range of products and services supporting the healthcare industry.
	Project outline: Supported the divestiture of a major division by providing interim management of the company’s entire Pacific Rim operations. Ensured compliance with legal and regulatory requirements. Strengthened management controls and maintained stability among local management and staff. The sale of the division was completed successfully well within the planned time frame.

Pharmaceutical market entry strategy – South East Asia

Client: Large U.S. specialty pharmaceutical company.

Project outline: Leveraging our extensive network of key opinion leaders, in-depth face-to-face interviews were conducted with leading neonatologists in Singapore, Malaysia, Thailand and Hong Kong. The client was presented with comprehensive country by country analyses providing details of current market dynamics for its main pharmaceutical product and delivery device. A regulatory roadmap was developed and distribution partners were identified, evaluated and appointed in each of the four markets.

Market opportunity assessment and entry strategy - India

Client: World leader in infection control and operating room equipment.

Project outline: More than 150 face-to-face interviews were conducted with leading Indian hospitals and industry experts in eight major cities across the country. This was followed by a broad competitor analysis. Through the interviews and through extensive secondary research we identified key market drivers as well as both short and long term product opportunities. The final report and recommendations provided detailed practical advice on how to best exploit these opportunities.

Market research and entry strategy development

	Client: Publicly listed Singapore-based manufacturer of precision engineered components evaluating possible diversification into medical devices, including orthopaedic implants.
	Project outline: Conducted extensive primary market research in Europe and the U.S. Provided a detailed map of the orthopaedic industry supply chain, identified and quantified major opportunities and proposed a market entry strategy. We delivered a detailed document and presentation to our client who was able to make an informed market entry decision.

Biopharmaceutical opportunity

	Client: Venture-backed German biopharmaceutical company developing innovative therapeutic proteins for the treatment of stroke.
	Project outline: Establishment of a clinical trial network and an R&D centre in Asia through partnerships and alliances with private and government organisations. Assistance in raising funds from venture capital groups as well as from local government grants and incentive schemes.

Strategic distribution alliance

	Client: Major U.S. multinational in in-vitro diagnostics.
	Project outline: Identified, evaluated and met with 40+ point-of-care diagnostics manufacturers for a strategic distribution alliance in Asia-Pacific. Examined potential synergies and strategic fit. Compiled detailed company profiles and recommended first and second priority targets.

Back to Top